Suchergebnisse - "Tai, W.T."

PubPharm (13)

1

SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma

enthalten in: Oncogene | 2017

von Fan, L. | Shiau, C. | Tai, W. | +6

ErratumFor: Oncogene. 2015 Oct 8;34(41):5252-63. - PMID 25619838

2

Upregulation of the oncoprotein SET determines poor clinical outcomes in hepatocellular carcinoma and shows therapeutic potential

enthalten in: Oncogene | 2016

von Hung, M. | Chen, Y. | Chu, P. | +5

3

SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma

enthalten in: Oncogene | 2015

von Fan, L. | Shiau, C. | Tai, W. | +6

ErratumIn: Oncogene. 2017 Jul 17;:. - PMID 28714962

4

SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma

enthalten in: International journal of pharmaceutical medicine | 2015

von Fan, L. | Shiau, C. | Tai, W. | +6

5

723: A sorafenib derivative and novel SHP-1 agonist, SC-59, acts synergistically with radiotherapy in hepatocellular carcinoma cells through inhibition of STAT3

enthalten in: The European journal of cancer / A | 2014

von Huang, C. | Tai, W. | Hsieh, C. | +5

6

Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells

enthalten in: Cell death & disease | 2013

von Tai, W. | Shiau, C. | Chen, H. | +5

7

82 Sorafenib and Its Derivative SC-59 Induces Autophagy in Hepatocellular Carcinoma Through SHP-1 Dependent Inhibition of STAT3

enthalten in: The European journal of cancer / A | 2012

von Chen, H. | Tai, W. | Shiau, C. | +5

8

Targeted therapy with fatty acid synthase inhibitors in a human prostate carcinoma LNCaP/tk-luc-bearing animal model

enthalten in: Prostate cancer and prostatic diseases | 2012

von Chen, H. | Chang, Y. | Chuang, H. | +2

9

1056 POSTER Sorafenib Sensitizes Hepatocellular Carcinoma Cells to Radiation-induced Apoptosis Through the Inhibition of Signal Transducers and Activators of Transcription 3

enthalten in: The European journal of cancer / A | 2011

von Chen, K. | Huang, C. | Wei, C. | +2

10

1027 Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of signal transducers and activators of transcription 3

enthalten in: European journal of cancer / EJC Supplements | 2009

von Chen, K. | Liu, T. | Tai, W. | +2